Alkermes plc. — Director's Dealing 2021

Jan 15, 2021

SEC Form 4/A — Form 4/A

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2020-02-21

Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-21	Ordinary Shares	M	6875	—	Acquired	15955	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Restricted Stock Unit Award	$0	M	6875	Disposed		Ordinary Shares (6875)	Direct

Footnotes

F1: Table II of the Form 4 filed on February 24, 2020 inadvertently reported an exercise by the reporting person of an employee stock option in lieu of reporting the vesting of a restricted stock unit award.??This amendment is being filed to correct Table II to show the vesting of such restricted stock unit award.??All other information reported in the original Form 4 remains the same.

F2: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020.